Literature DB >> 16928383

Pressure overload induces greater hypertrophy and mortality in female mice with p38alpha MAPK inhibition.

Jing Liu1, Junichi Sadoshima, Peiyong Zhai, Chull Hong, Guiping Yang, Wei Chen, Lin Yan, Yibin Wang, Stephen F Vatner, Dorothy E Vatner.   

Abstract

We examined pressure overload left ventricular (LV) hypertrophy (H) induced by aortic banding in transgenic mice with cardiac-specific expression of a dominant negative (DN) p38alpha (TG) and wild type controls (WT). In response to chronic pressure overload, induced by aortic constriction, LV/BW increased more, p<0.05, in female TG (6.4+/-0.2, n=7) than in WT female (5.1+/-0.2, n=10), or male TG or WT (5.0+/-0.2, n=10 vs. 5.5+/-0.2, n=8). Lung/BW, an index of LV decompensation, was significantly higher, p<0.05, in banded female TG (14+/-1.2 mg/g) than in WT females (9.0+/-0.8), or male TG or WT (8.2+/-0.7 vs. 9.3+/-1.3). This was associated with higher premature mortality, p<0.05, in banded female TG mice (42%) compared with banded WT females (10%), TG males (13%), or WT males (17%). In male, but not female, TG mice, the number of TUNEL-positive cells was smaller, p<0.05, compared with WT. Phospho-Akt kinase activity increased (p<0.05) in female TG after banding, but not in males. After ovariectomy, chronic pressure overload no longer induced greater mortality, greater LVH, or p-Akt levels in female TG mice, and like male TG mice, apoptosis was protected. DN-p38alpha enhanced estrogen-induced activation of Akt in cultured cardiac myocytes. Thus, inhibition of p38alpha MAPK paradoxically augments LVH resulting in cardiac decompensation and increased mortality in response to pressure overload more in female mice than male mice, which could be due to increased Akt activation and/or through cross-talk between p38alpha MAPK and Akt.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16928383     DOI: 10.1016/j.yjmcc.2006.07.007

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  8 in total

Review 1.  Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale.

Authors:  Beth A Rose; Thomas Force; Yibin Wang
Journal:  Physiol Rev       Date:  2010-10       Impact factor: 37.312

Review 2.  Myocardial AKT: the omnipresent nexus.

Authors:  Mark A Sussman; Mirko Völkers; Kimberlee Fischer; Brandi Bailey; Christopher T Cottage; Shabana Din; Natalie Gude; Daniele Avitabile; Roberto Alvarez; Balaji Sundararaman; Pearl Quijada; Matt Mason; Mathias H Konstandin; Amy Malhowski; Zhaokang Cheng; Mohsin Khan; Michael McGregor
Journal:  Physiol Rev       Date:  2011-07       Impact factor: 37.312

3.  Distinctive ERK and p38 signaling in remote and infarcted myocardium during post-MI remodeling in the mouse.

Authors:  Che-Chung Yeh; Hongzhe Li; Deepak Malhotra; Sally Turcato; Susan Nicholas; Richard Tu; Bo-Qing Zhu; John Cha; Philip M Swigart; Bat-Erdene Myagmar; Anthony J Baker; Paul C Simpson; Michael J Mann
Journal:  J Cell Biochem       Date:  2010-04-15       Impact factor: 4.429

Review 4.  The Importance of Biological Sex and Estrogen in Rodent Models of Cardiovascular Health and Disease.

Authors:  Christa L Blenck; Pamela A Harvey; Jane F Reckelhoff; Leslie A Leinwand
Journal:  Circ Res       Date:  2016-04-15       Impact factor: 17.367

Review 5.  Computational models of cardiac hypertrophy.

Authors:  Kyoko Yoshida; Jeffrey W Holmes
Journal:  Prog Biophys Mol Biol       Date:  2020-07-21       Impact factor: 3.667

Review 6.  Protein Kinases as Drug Development Targets for Heart Disease Therapy.

Authors:  Naranjan S Dhalla; Alison L Müller
Journal:  Pharmaceuticals (Basel)       Date:  2010-07-05

Review 7.  The Role of PKC-MAPK Signalling Pathways in the Development of Hyperglycemia-Induced Cardiovascular Complications.

Authors:  Fatin Farhana Jubaidi; Satirah Zainalabidin; Izatus Shima Taib; Zariyantey Abdul Hamid; Nur Najmi Mohamad Anuar; Juriyati Jalil; Nor Anizah Mohd Nor; Siti Balkis Budin
Journal:  Int J Mol Sci       Date:  2022-08-02       Impact factor: 6.208

Review 8.  Glucagon-like peptide-1 (GLP-1) and protective effects in cardiovascular disease: a new therapeutic approach for myocardial protection.

Authors:  Ting C Zhao
Journal:  Cardiovasc Diabetol       Date:  2013-06-18       Impact factor: 9.951

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.